1. Home
  2. LNN vs SUPN Comparison

LNN vs SUPN Comparison

Compare LNN & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LNN
  • SUPN
  • Stock Information
  • Founded
  • LNN 1954
  • SUPN 2005
  • Country
  • LNN United States
  • SUPN United States
  • Employees
  • LNN N/A
  • SUPN N/A
  • Industry
  • LNN Industrial Machinery/Components
  • SUPN Biotechnology: Pharmaceutical Preparations
  • Sector
  • LNN Industrials
  • SUPN Health Care
  • Exchange
  • LNN Nasdaq
  • SUPN Nasdaq
  • Market Cap
  • LNN 1.5B
  • SUPN 1.7B
  • IPO Year
  • LNN 1988
  • SUPN 2012
  • Fundamental
  • Price
  • LNN $134.26
  • SUPN $31.70
  • Analyst Decision
  • LNN Hold
  • SUPN Hold
  • Analyst Count
  • LNN 1
  • SUPN 2
  • Target Price
  • LNN $128.00
  • SUPN $36.00
  • AVG Volume (30 Days)
  • LNN 71.0K
  • SUPN 420.5K
  • Earning Date
  • LNN 06-26-2025
  • SUPN 05-06-2025
  • Dividend Yield
  • LNN 1.07%
  • SUPN N/A
  • EPS Growth
  • LNN 12.44
  • SUPN N/A
  • EPS
  • LNN 7.03
  • SUPN 1.11
  • Revenue
  • LNN $647,542,000.00
  • SUPN $667,997,000.00
  • Revenue This Year
  • LNN $11.29
  • SUPN N/A
  • Revenue Next Year
  • LNN $3.37
  • SUPN $9.14
  • P/E Ratio
  • LNN $19.08
  • SUPN $28.49
  • Revenue Growth
  • LNN 0.46
  • SUPN 11.82
  • 52 Week Low
  • LNN $109.27
  • SUPN $25.53
  • 52 Week High
  • LNN $140.26
  • SUPN $40.28
  • Technical
  • Relative Strength Index (RSI)
  • LNN 60.59
  • SUPN 47.88
  • Support Level
  • LNN $130.72
  • SUPN $29.16
  • Resistance Level
  • LNN $136.00
  • SUPN $33.28
  • Average True Range (ATR)
  • LNN 3.47
  • SUPN 1.19
  • MACD
  • LNN 0.78
  • SUPN 0.02
  • Stochastic Oscillator
  • LNN 86.87
  • SUPN 61.65

About LNN Lindsay Corporation

Lindsay Corp provides various proprietary water management and road infrastructure products and services. It has operations categorized into two main reporting segments: Irrigation, and Infrastructure. The company generates maximum revenue from the Irrigation segment. Its Irrigation segment includes manufacturing and marketing center pivot, lateral move, and hose reel irrigation systems, as well as various technology solutions such as GPS positioning and guidance, variable rate irrigation, wireless irrigation management, M2M communication technology, and smartphone applications. Geographically, it derives a majority of its revenue from the United States.

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.

Share on Social Networks: